Jeff Coller
Jeff Coller is a prominent scientist specializing in mRNA technology and a professor at Johns Hopkins University. He has been instrumental in advancing the understanding of mRNA's potential, particularly in the context of cancer treatment. Recently, he was in the news for his involvement in a groundbreaking study that found mRNA vaccines, initially designed for COVID-19, could significantly enhance the immune response in cancer patients, leading to improved survival rates. This research marks a pivotal moment in the development of therapies aimed at harnessing the body's immune system to combat various cancers.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Panama | 1 | 5.00 | 0.09% | +0% | 4,314,768 | 4,051 | $76,000 | 71$ |
| United Kingdom | 1 | 5.00 | 0.05% | +0% | 67,886,011 | 33,164 | $2,700,000 | 1,319$ |
| Totals | 2 | 72,200,779 | 37,215 | $2,776,000 | 1,390$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Panama:
Jeff Coller, a distinguished professor at Johns Hopkins University, commented on the impact of funding cuts on RNA research.
5
United Kingdom:
Jeff Coller highlighted the chilling effect of funding cuts on mRNA research.
5
Liechtenstein:
Jeff Coller is a professor of biology and RNA therapeutics at Johns Hopkins University.
7
Portugal:
Jeff Coller is a scientist specializing in mRNA technology who emphasized the revolutionary impact of mRNA medications in cancer treatment.
9